The role of serum nesfatin-1 in predicting metabolic syndrome among patients with overweight

Z. Alsarraf; M. H. Mohammed; F. Haitham

doi:10.15421/0225123

Z. Alsarraf University of Ninevah
M. H. Mohammed University of Mosul
F. Haitham University of Mosul

Keywords: appetite suppression, nesfatin-1, obesity, metabolic syndrome.

Abstract

Nesfatin-1 biomarker could have a promoting key role in the diagnosis and management of many metabolic disorders. However; till now, the exact role of nesfatin -1 in human s still need s further studies. The study presented here was conducted on 40 individuals who were divided into two groups, 20 patients with metabolic syndrome (cases) and 20 healthy people (controls). In addition to sociodemographic and anthropometric measurements, circulating levels of serum lipid profile, fasting blood sugar, insulin resistant (HOMA), serum nesfatin -1 level were measured. All of the study participants also had their blood pressure measured. No significant difference was found between the two groups regarding nesfatin -1 level, but nesfatin -1 was significantly in negative correlation with serum triglyceride , and lastly nesfatin -1 showed accepted prediction outcome of metabolic syndrome.

References

Abed, B. A., Farhan, L. O., & Dawood, A. S. (2024). Relationship between serum nesfatin-1, adiponectin, resistin concentration and obesity with type 2 diabetes mellitus. Baghdad Science Journal, 21(1), 117–123.

Afifi, M. A., Khalil, F. M., El Assal, M. A., Matueny, R. M., & Rizk, M. (2024). Serum nesfatin-1 in patients with metabolic associated fatty liver disease. The Egyptian Journal of Hospital Medicine, 94(1), 1056–1062.

Alotibi, M. N., Alnoury, A. M., & Alhozali, A. M. (2019). Serum nesfatin-1 and galanin concentrations in the adult with metabolic syndrome. Saudi Medical Journal, 40(1), 19–25.

Ambroselli, D., Masciulli, F., Romano, E., Catanzaro, G., Besharat, Z. M., Massari, M. C., Ferretti, E., Migliaccio, S., Izzo, L., Ritieni, A., Grosso, M., Formichi, C., Dotta, F., Frigerio, F., Barbiera, E., Giusti, A. M., Ingallina, C., & Mannina, L. (2023). New advances in metabolic syndrome, from prevention to treatment: The role of diet and food. Nutrients, 15(3), 640.

Angelico, F., Baratta, F., Coronati, M., Ferro, D., & Del Ben, M. (2023). Diet and metabolic syndrome: A narrative review. Internal and Emergency Medicine, 18(4), 1007–1017.

Anton-Păduraru, D. T., Mindru, D. E., Stănescu, R. S., Trofin, F., Cobuz, C., Cobuz, M., Sur, L. M., Petroaie, A., Slănină, A. M., Manole, M., Bocec, A. S., & Cosmescu, A. (2025). Unraveling metabolic syndrome in youth: The obesity epidemic's hidden complication. Children, 12(4), 482.

Bovolini, A., Garcia, J., Andrade, M. A., & Duarte, J. A. (2021). Metabolic syndrome pathophysiology and predisposing factors. International Journal of Sports Medicine, 42(3), 199–214.

Chen, Y. L., Li, H., Li, S., Xu, Z., Tian, S., Wu, J., Liang, X. Y., Li, X., Liu, Z. L., Xiao, J., Wei, J. Y., Ma, C. Y., Wu, K. N., Ran, L., & Kong, L. Q. (2021). Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study. BMC gastroenterology, 21(1), 212.

Cifuentes, M., Vahid, F., Devaux, Y., & Bohn, T. (2024). Biomarkers of food intake and their relevance to metabolic syndrome. Food and function, 15(14), 7271–7304.

Duc, N. M., Nghiem, M. N., Vo, T. T. B., Nguyen, M. T., & Dao, S. T. (2023). A cross-sectional study on the nesfatin-1 serum levels of Vietnamese patients with pre-diabetes. Revista da Associacao Medica Brasileira, 69(5), e20221388.

Fahed, G., Aoun, L., Bou Zerdan, M., Allam, S., Bou Zerdan, M., Bouferraa, Y., & Assi, H. I. (2022). Metabolic syndrome: Updates on pathophysiology and management in 2021. International Journal of Molecular Sciences, 23(2), 786.

Gan, H. W., Cerbone, M., & Dattani, M. T. (2024). Appetite- and weight-regulating neuroendocrine circuitry in hypothalamic obesity. Endocrine Reviews, 45(3), 309–342.

Jha, B. K., Sherpa, M. L., Imran, M., Mohammed, Y., Jha, L. A., Paudel, K. R., & Jha, S. K. (2023). Progress in understanding metabolic syndrome and knowledge of its complex pathophysiology. Diabetology, 4(2), 134–159.

Karvane, H. B., Esfandiari, H., Qutaiba, O., Allela, B., Mahdi, M. S., Al-Nuaimi, A. M. A., Al-Hussein, R. K. A., Jawad, M. J., Ghayourvahdat, A., & Keshavarzian, A. (2024). Metabolic syndrome in association with novel dietary index, metabolic parameters, nesfatin-1 and omentin-1. BMC Endocrine Disorders, 24(1), 257.

Khalil Ibrahim Al-Yassiri, I., Al-Tu’ma, F. J., Abbood Mukheef, M., Baqir Jawad, K., & Abdul-Kareem Mutar, B. (2023). Association between nesfatin-1 levels and C-peptide in sera of obese / non-obese type 2 diabetic women. Journal of Contemporary Medical Sciences, 9(1), 56–62.

Luna-Luna, M., Medina-Urrutia, A., Vargas-Alarcón, G., Coss-Rovirosa, F., Vargas-Barrón, J., & Pérez-Méndez, Ó. (2015). Adipose tissue in metabolic syndrome: Onset and progression of atherosclerosis. Archives of Medical Research, 46(5), 392–407.

Luo, J. J., Wen, F. J., Qiu, D., & Wang, S. Z. (2021). Nesfatin-1 in lipid metabolism and lipid-related diseases. Clinica Chimica Acta, 522, 23–30.

Madan, K., Paliwal, S., Sharma, S., Kesar, S., Chauhan, N., & Madan, M. (2023). Metabolic syndrome: The constellation of co-morbidities, a global threat. Endocrine, Metabolic and Immune Disorders Drug Targets, 23(12), 1491–1504.

Masenga, S. K., Kabwe, L. S., Chakulya, M., & Kirabo, A. (2023). Mechanisms of oxidative stress in metabolic syndrome. International Journal of Molecular Sciences, 24(9), 7898.

Mohajan, D., & Mohajan, H. K. (2023). Body mass index (BMI) is a popular anthropometric tool to measure obesity among adults. Journal of Innovations in Medical Research, 2(4), 25–33.

Mohamed, S. M., Shalaby, M. A., El-Shiekh, R. A., El-Banna, H. A., Emam, S. R., & Bakr, A. F. (2023). Metabolic syndrome: Risk factors, diagnosis, pathogenesis, and management with natural approaches. Food Chemistry Advances, 3, 100335.

Nasri, A., Kowaluk, M., Widenmaier, S. B., & Unniappan, S. (2024). Nesfatin-1 and nesfatin-1-like peptide attenuate hepatocyte lipid accumulation and nucleobindin-1 disruption modulates lipid metabolic pathways. Communications Biology, 7(1), 623.

Nouri-Keshtkar, M., Shojaei Shahrokhabadi, M., Ghaheri, A., Hosseini, R., Ketabi, H., Farjam, M., Chen, D. G., Rezaeian, M., Homayounfar, R., Tahamtani, Y., & Totonchi, M. (2023). Role of gender in explaining metabolic syndrome risk factors in an Iranian rural population using structural equation modelling. Scientific Reports, 13(1), 16007.

Palmeira, J. P., Oliveira, M. C., Santos, E. S., Sigler, R., Nunes, L. A., & Casotti, C. A. (2025). Analysis of the prevalence of metabolic syndrome and NCEP ATP III criteria in older people. International Journal of Cardiovascular Sciences, 38, e20240199.

Saldanha, J. F., Carrero, J. J., Lobo, J. C., Stockler-Pinto, M. B., Leal, V. O., Calixto, A., Geloneze, B., & Mafra, D. (2012). The newly identified anorexigenic adipokine nesfatin-1 in hemodialysis patients: Are there associations with food intake, body composition and inflammation? Regulatory Peptides, 173(1–3), 82–85.

Srivastav, S. K., Mir, I. A., Bansal, N., Singh, P. K., Kumari, R., & Deshmukh, A. (2022). Serum ferritin in metabolic syndrome-mechanisms and clinical applications. Pathophysiology, 29(2), 319–325.

Tekin, T., Çiçek, B., Konyalıgil, N., Güntürk, İ., Yazıcı, C., Karaca, Z., & Ünlüsavuran, M. (2020). Increased hip circumference in individuals with metabolic syndrome affects serum nesfatin-1 levels. Postgraduate Medical Journal, 96(1140), 600–605.

Toh, P. W. (2021). Evaluation of nesfatin-1 expression in lean, overweight, and diabetic cats. University of Saskatchewan, Saskatoon.

Yang, J., Qiu, H., Li, H., Zhang, Y., Tao, X., & Fan, Y. (2015). Body mass index, waist circumference and cut-off points for metabolic syndrome in urban residents in Ningxia. Open Journal of Endocrine and Metabolic Diseases, 5(12), 163–170.

Zamil, A. H., & Amin, S. S. (2022). The prevalence of metabolic syndrome among university students in Wasit, Iraq. Saudi Medical Journal, 43(11), 1240–1247.